349 related articles for article (PubMed ID: 19345524)
1. Structure elucidation of a new designer benzylpiperazine: 4-bromo-2,5-dimethoxybenzylpiperazine.
Westphal F; Junge T; Girreser U; Stobbe S; Pérez SB
Forensic Sci Int; 2009 May; 187(1-3):87-96. PubMed ID: 19345524
[TBL] [Abstract][Full Text] [Related]
2. Structure elucidation of a novel analogue of sildenafil detected as an adulterant in an herbal dietary supplement.
Reepmeyer JC; Woodruff JT; d'Avignon DA
J Pharm Biomed Anal; 2007 Apr; 43(5):1615-21. PubMed ID: 17207601
[TBL] [Abstract][Full Text] [Related]
3. Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs).
Rösner P; Quednow B; Girreser U; Junge T
Forensic Sci Int; 2005 Mar; 148(2-3):143-56. PubMed ID: 15639609
[TBL] [Abstract][Full Text] [Related]
4. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
[TBL] [Abstract][Full Text] [Related]
5. Mass spectral and NMR spectral data of two new designer drugs with an alpha-aminophenone structure: 4'-methyl-alpha-pyrrolidinohexanophenone and 4'-methyl-alpha-pyrrolidinobutyrophenone.
Westphal F; Junge T; Rösner P; Fritschi G; Klein B; Girreser U
Forensic Sci Int; 2007 Jun; 169(1):32-42. PubMed ID: 16962275
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance.
Frison G; Zamengo L; Zancanaro F; Tisato F; Traldi P
Rapid Commun Mass Spectrom; 2016 Jan; 30(1):151-60. PubMed ID: 26661982
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-β-phenethylamine (2C-G)--a new designer drug.
Zuba D; Sekuła K
Drug Test Anal; 2013 Jul; 5(7):549-59. PubMed ID: 22927304
[TBL] [Abstract][Full Text] [Related]
8. Regioisomeric bromodimethoxy benzyl piperazines related to the designer substance 4-bromo-2,5-dimethoxybenzylpiperazine: GC-MS and FTIR analysis.
Abdel-Hay KM; DeRuiter J; Clark CR
Forensic Sci Int; 2014 Jul; 240():126-36. PubMed ID: 24819165
[TBL] [Abstract][Full Text] [Related]
9. Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: a designer drug with alpha-pyrrolidinophenone structure.
Westphal F; Junge T; Rösner P; Sönnichsen F; Schuster F
Forensic Sci Int; 2009 Sep; 190(1-3):1-8. PubMed ID: 19500924
[TBL] [Abstract][Full Text] [Related]
10. New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine.
Staack RF; Fritschi G; Maurer HH
J Mass Spectrom; 2003 Sep; 38(9):971-81. PubMed ID: 14505325
[TBL] [Abstract][Full Text] [Related]
11. Application of GC-EI-MS for the identification and investigation of positional isomer in primaquine, an antimalarial drug.
Dongre VG; Karmuse PP; Nimbalkar MM; Singh D; Kumar A
J Pharm Biomed Anal; 2005 Sep; 39(1-2):111-6. PubMed ID: 15905064
[TBL] [Abstract][Full Text] [Related]
12. Qualitative analysis of seized synthetic cannabinoids and synthetic cathinones by gas chromatography triple quadrupole tandem mass spectrometry.
Gwak S; Arroyo-Mora LE; Almirall JR
Drug Test Anal; 2015 Feb; 7(2):121-30. PubMed ID: 24827678
[TBL] [Abstract][Full Text] [Related]
13. Identification of steroid isoxazole isomers marketed as designer supplement.
Parr MK; Gütschow M; Daniels J; Opfermann G; Thevis M; Schänzer W
Steroids; 2009 Mar; 74(3):322-8. PubMed ID: 19061909
[TBL] [Abstract][Full Text] [Related]
14. An analytical approach to the forensic identification of different classes of new psychoactive substances (NPSs) in seized materials.
Strano Rossi S; Odoardi S; Gregori A; Peluso G; Ripani L; Ortar G; Serpelloni G; Romolo FS
Rapid Commun Mass Spectrom; 2014 Sep; 28(17):1904-16. PubMed ID: 25088134
[TBL] [Abstract][Full Text] [Related]
15. The use of HPLC/MS, GC/MS, NMR, UV and IR to identify a degradation product of eperisone hydrochloride in the tablets.
Ding L; Wang X; Yang Z; Chen Y
J Pharm Biomed Anal; 2008 Jan; 46(2):282-7. PubMed ID: 18023316
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the designer drug bk-2C-B (2-amino-1-(bromo-dimethoxyphenyl)ethan-1-one) by gas chromatography/mass spectrometry without and with derivatization with 2,2,2-trichloroethyl chloroformate, liquid chromatography/high-resolution mass spectrometry, and nuclear magnetic resonance.
Frison G; Odoardi S; Frasson S; Sciarrone R; Ortar G; Romolo FS; Strano Rossi S
Rapid Commun Mass Spectrom; 2015 Jul; 29(13):1196-204. PubMed ID: 26395784
[TBL] [Abstract][Full Text] [Related]
17. Structure elucidation of a novel synthetic thiono analogue of sildenafil detected in an alleged herbal aphrodisiac.
Venhuis BJ; Zomer G; de Kaste D
J Pharm Biomed Anal; 2008 Mar; 46(4):814-7. PubMed ID: 18207347
[TBL] [Abstract][Full Text] [Related]
18. Criteria for determining purity of Fusarium mycotoxins.
Bennett GA; Shotwell OL
J Assoc Off Anal Chem; 1990; 73(2):270-5. PubMed ID: 2324038
[TBL] [Abstract][Full Text] [Related]
19. Characterization of tetra-aryl benzene isomers by using preparative gas chromatography with mass spectrometry, nuclear magnetic resonance spectroscopy, and X-ray crystallographic methods.
Rühle CP; Niere J; Morrison PD; Jones RC; Caradoc-Davies T; Canty AJ; Gardiner MG; Tolhurst VA; Marriott PJ
Anal Chem; 2010 Jun; 82(11):4501-9. PubMed ID: 20441219
[TBL] [Abstract][Full Text] [Related]
20. Spectroscopic characterization of 3,4-methylenedioxypyrrolidinobutyrophenone: a new designer drug with α-pyrrolidinophenone structure.
Westphal F; Junge T; Klein B; Fritschi G; Girreser U
Forensic Sci Int; 2011 Jun; 209(1-3):126-32. PubMed ID: 21316166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
